Drug intelligence / Profile preview

Regenera

Development stage
Unknown
Lead developer
Eye Pharma
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic, Topical
01

Overview

Regenera is a therapeutic contact lens medical device developed by Eye Pharma S.p.A. for the treatment of ocular surface injuries and healing conditions. The lens is manufactured from Filcon II 3 hydrogel with a 75% water content and features an inverse geometry with a 16.5 mm diameter. It is supplied in a preservation solution containing hyaluronic acid and aloe vera, which provide regenerating, anti-inflammatory, and analgesic properties. Regenera is indicated for conditions such as keratitis, corneal hypoxia syndrome, corneal trauma, ulcers, and abrasions, and it serves as an ocular bandage in post-surgical therapy. The device is designed for continuous wear for up to 7 consecutive days, facilitating the repair and regeneration of the ocular surface through both physical protection and the delivery of therapeutic agents.

Brand names
Regenera
Other names
Regenera-Eye Pharma
02

Targets

CD44 (CD44 antigen)COX

Beyond the preview

Go deeper on Regenera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenera.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call